Scinovex
articleTop 1% cited

Assessment of BRAF V600E mutation status by immunohistochemistry with a mutation-specific monoclonal antibody

Acta Neuropathologica · 2011 · Vol. 122(1) · pp. 11–19
David CapperMatthias PreusserAntje HabelFelix SahmUlrike AckermannGenevieve SchindlerStefan PuschGunhild MechtersheimerHanswalter ZentgrafAndreas von Deimling
Melanoma and MAPK PathwaysCellular Mechanics and InteractionsHER2/EGFR in Cancer ResearchImmunohistochemistryMutationV600ECancer researchPathologyMonoclonal antibodyBiologyMelanomaAntibodyclone (Java method)

MeSH terms

AnimalsAntibodies, MonoclonalBrain NeoplasmsCarcinoma, PapillaryFemaleHumansImmunohistochemistryMelanomaMice, Inbred C57BLMutationPredictive Value of TestsPrognosisThyroid NeoplasmsBiomarkers, TumorProto-Oncogene Proteins B-raf

Funding

  • Bundesministerium für Bildung und Forschung
Citation Network

How this paper connects to the literature. Drag to explore, click any node to open that paper.

Assessment of BRAF V600E mutation status by immunohistochemistry with a mutation-specific monoclonal antibody · Scinovex